Niraparib + Dostarlimab + RT in Pancreatic Cancer
Phase 2 Completed
18 enrolled 11 charts
CA209-9KH
Phase 1/2 Completed
15 enrolled
SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer
Phase 1 Completed
6 enrolled
Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 2 Completed
154 enrolled
Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
82 enrolled
Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer
Phase 2 Completed
22 enrolled 9 charts
Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 1 Completed
1 enrolled
Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer
Phase 2 Completed
41 enrolled
Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer
Phase 2 Completed
71 enrolled 9 charts
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers
Phase 2 Completed
50 enrolled 21 charts
Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery
Phase 2 Completed
137 enrolled 8 charts
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Phase 2 Completed
50 enrolled
Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
Phase 1 Completed
28 enrolled